In 2022, the Global Point Of Care (POC) Diagnostics/Testing Market was valued at USD 43.2 Billion and is projected to reach a market size of USD 98.13 Billion by 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 10.8%.
 DIAGNOSTICS MARKET.png)
Industry Overview:
The point-of-care (POC) diagnostics/testing are medical devices used to get an instant result in the investigation (diagnosis & monitoring) of various diseases, including cancer, diabetes, cardiac diseases, and others. Factors such as the increasing prevalence of respiratory diseases (such as COVID-19 and influenza) around the world, increase in the geriatric population, sedentary lifestyles, and improved access to point-of-care devices through online platforms, are driving the growth of the point-of-care diagnostics market. Point-of-care diagnostics/testing is gaining wide acceptance by different patients worldwide, as the results can be achieved in less time, owing to the use of nano diagnostics, micro fluids, and chips. The growing number of regulatory approvals for novel immunoassay techniques, the rising usage of home-based POC devices, and technological advancements are anticipated to fuel the market growth, over the forecast period.
Impact of COVID-19 outbreak on Point of Care (POC) Diagnostics/Testing Market:
The COVID-19 pandemic has accelerated the global demand for diagnostic kits to rapidly detect the disease. Market players are focusing on increasing the supply of tests worldwide as many countries are facing a severe shortage of laboratory-based molecular assays. The need for speedy diagnostic test results has made point-of-care testing an important diagnostic tool. The rapid growth in the cases of COVID-19 and pressure on governments to improve patient management have boosted the demand for rapid antigen testing kits that can be used in point-of-care settings. COVID-19 rapid kits are to detect COVID-19. Thus, an increase in the prevalence of COVID-19 has surged the demand for point-of-care diagnostics kits. The increase in approvals of at-home POC test kits for detecting COVID-19 has significantly contributed to the growth of the market. Abbott's BinaxNOW rapid test was recently approved by U.S. FDA for at-home use.
MARKET DRIVERS:
The growing geriatric population and high prevalence of infectious diseases across the globe are driving the growth of the market:
The elderly population is rapidly increasing. According to the World Health Organization, the number of people aged 65 and up is estimated to increase by around 1.5 billion by 2050. Cancer, high blood pressure, diabetes, and blood sugar levels are some of the health issues that the geriatric population faces. The growing geriatric population is likely to drive the growth of the point of care diagnostics market in the coming years. POC tests improve the management of infectious diseases, especially in developing economies where access to timely medical care is a challenge with poor healthcare infrastructure. The rising prevalence of infectious diseases and inadequate healthcare infrastructural facilities in developing nations is anticipated to drive the adoption of POC testing.
Growing focus on microfluidics platforms, technological advancements, and emerging markets are some factors likely to fuel the growth of the Point of Care Diagnostics Market:
The efficiency of point of care diagnostics has revolutionized patient care. With advancements in the field of microfluidics, point of care technologies has also improved. Methods in microfabrication and microfluidics have evolved in the last few years that allow POC devices to be fabricated at low cost, generate rapid results, are easy to use, and are portable. Emerging markets such as China, India, and Brazil are likely to offer significant growth opportunities for players operating in the point of care diagnostics market. This is attributable to the high prevalence of infectious and lifestyle diseases in emerging countries. Manufacturers are focusing on acquiring or entering into agreements and partnerships with regional players for product distribution and manufacturing to meet the increasing demand for POC diagnostics in emerging markets.
MARKET RESTRAINTS:
The stringent regulatory framework can hamper the development of new point of care diagnostics test kits and thus, negatively affect the market growth:
The stringent regulatory policies have affected the development of new point of care diagnostics test kits, despite their improved accuracy and capabilities. The diagnostic test is approved by the Food and Drug Administration (FDA) in the U.S., for which it must go through a lengthy regulatory process. Businesses developing new products need to get strict laws passed. The stringent regulatory authorities’ enforcement of regulations on a certain point of care diagnostics testing kits threatens the development of novel diagnostic kits.
Pricing pressure owing to reimbursement cuts and budget constraints can hamper the Point of Care (POC) Diagnostics Market growth:
The pricing pressure caused by reimbursement and insufficient budgets impacts the growth of the global point of care diagnostics market. According to the US government healthcare reform bill (2013), manufacturers must pay a heavy 2.3% annual excise tax on medical devices. In France, the cost of patient care is rolled out into one prospective payment under the Diagnosis Related Group (DRG) system, which makes reimbursement a negligible factor. Expenditure on general-use medical devices is stagnating owing to a decrease in the number of healthcare products eligible for reimbursement. Manufacturers thus find it challenging to support prices and prevent margin erosion as competition intensifies.
POINT OF CARE POC) DIAGNOSTICS/TESTING MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2022 - 2030 |
|
Base Year |
2022 |
|
Forecast Period |
2023 - 2030 |
|
CAGR |
10.8% |
|
Segments Covered |
By Product, Mode of Prescription, Platform, End-User and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Abbott Laboratories (US), Thermo Fisher Scientific (US), Siemens Healthineers AG (Germany), Nova Biomedical (US), Quidel Corporation (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US),Chembio Diagnostics (US), EKF Diagnostics (UK), Trinity Biotech plc (Ireland), Instrumentation Laboratory (a Werfen Company) (US), PTS Diagnostics (US), Sekisui Diagnostics (US), bioMérieux S.A. (France) |
This research report on the global Pont of Care (POC) Diagnostics/Testing Market has been segmented and sub-segmented based on product, mode of prescription, platform, end-user, and region.
Blood Glucose Monitoring Testing
Strips
Meters
Lancets & Lancing Devices
Cardiac-Metabolism Monitoring Testing
Cardiac Marker
HbA1c Testing
Blood Gas/Electrolytes Testing
Infectious Disease Testing
Influenza Testing
HIV Testing
Hepatitis C Testing
Healthcare-Associated Infection (HAI) Testing
Respiratory Infection Testing
Sexually Transmitted Disease (STD) Testing
Tropical Disease Testing
Other Infectious Disease Testing
Coagulation Monitoring
Prothrombin Time (PT/INR) Testing
Activated Clotting Time (ACT/aPTT) Testing
Pregnancy and Fertility Testing Products
Pregnancy Testing
Fertility Testing
Tumor/Cancer Markers Testing
Cholesterol Testing
Urinalysis Testing
Hematology Testing
Drugs of Abuse Testing
Fecal Occult Testing
Other POC Testing
Based on the Product, the Point of Care (POC) Diagnostics/Testing Market is bifurcated into Blood Glucose Monitoring Testing, Cardiac-Metabolism Monitoring Testing, Infectious Disease Testing, Coagulation Monitoring, Coagulation Monitoring, Tumor/Cancer Markers Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Drugs of Abuse Testing, Fecal Occult Testing, and Other POC Testing. The Blood Glucose Monitoring Testing segment holds the largest share in the market. The demand from diabetic patients to monitor their glucose levels regularly has prompted the adoption of point of care diagnostics among diabetic patients. The growing prevalence of diabetes around the world is anticipated to drive the segment growth. Blood glucose monitoring devices offer better glucose control and enable accurate treatment decisions. POC glucose monitoring kits are for analyzing results which are less invasive as compared to lab tests. These kits can also be easily used by diabetes patients to monitor their glucose levels and prevent complications.
Prescription-based Testing
Over-the-counter (OTC) Testing
Based on the Mode of Prescription, the Point of Care (POC) Diagnostics/Testing Market is bifurcated into prescription-based Testing and Over-the-counter (OTC) Testing. The Prescription-based point-of-care testing segment is growing rapidly as it is most frequently used in healthcare facilities and prescribed by healthcare professionals. The Over-the-counter (OTC) testing segment is anticipated to witness the fastest growth during the projected period owing to the cost reduction, quality improvement, convenience to patients and clinicians, and growing use of novel technologies such as nanotechnology, electrical impedance, microfluidics, reflectance, and time-resolved fluorescence, which allows the miniaturization of devices and the proliferation of point-of-care (POC) testing.
Lateral Flow Assays
Microfluidics
Dipsticks
Immunoassays
Molecular Diagnostics
Based on the Platform, the Point of Care (POC) Diagnostics/Testing Market is bifurcated into Lateral Flow Assays, Microfluidics, Dipsticks, Immunoassays, and Molecular Diagnostics. The Lateral Flow Assay segment dominates the global POC diagnostics market owing to its clinical utility and affordability. Moreover, this technology continuously evolving as POC testing demands higher performance. Lateral flow assays (LFA) are simple devices used for detecting the presence or absence of target analytes in samples. The Point of Care diagnostics market for Lateral flow assays has grown significantly In the past few years, owing to the increasing adoption of Lateral flow assays testing products in-home care settings. Companies are focusing on the development of innovative Lateral flow assay-based Point of Care devices. Molecular Diagnostics is rapidly gaining traction which is driving the segment.
Clinical Laboratories
Ambulatory Care Facilities and Physician Offices
Pharmacies, retail clinics, & E-comm. Platforms
Hospitals
Home Care & Self Testing
Other End Users
Based on End-User, the Point of Care (POC) Diagnostics/Testing Market is bifurcated into Clinical Laboratories, Ambulatory Care Facilities and Physician Offices, Pharmacies, retail clinics, & E-comm. Platforms, Hospitals, Home Care & Self Testing, and Other End Users. The Hospital segment accounts for a significant share in the Point of Care (POC) Diagnostics/Testing Market owing to the rising prevalence of chronic diseases. Home care/self-testing holds a major share of the global point of care diagnostics market, owing to the growing inclination for at-home healthcare, rising focus on continuous and remote monitoring, and growing need for rapid tests in home.
North America
Europe
Asia-Pacific
Rest of the World
Geographically, the North American Point of Care (POC) Diagnostics/Testing Market dominates the global market and is anticipated to grow significantly during the forecast period. This is attributed to
growing geriatric population, rising chronic diseases, and favorable government legislation and initiatives aimed at improving the healthcare infrastructure.
The European Point of Care (POC) Diagnostics/Testing Market is anticipated to grow significantly during the forecast period owing to the high prevalence of chronic diseases, integration of automated techniques in healthcare, and rise in new product launches in the region.
The Point of Care (POC) Diagnostics/Testing Market in the Asia Pacific has registered the highest growth rate and is anticipated to grow rapidly in developing countries particularly China, Japan, and India. This growth is attributed to the increasing demand for efficient and effective diagnostics, the growing prevalence of chronic diseases, and rising disposable income.
The Point of Care (POC) Diagnostics/Testing Market in Latin America, the Middle East, and Africa is anticipated to register high growth during the forecast period. Latin American point of care diagnostic market is likely to register high growth during the forecast period owing to supportive government efforts in increasing awareness about the early detection of diseases, increasing healthcare expenditures, and increasing the number of hospitals and clinical diagnostic laboratories.
Major Key Players in the Market:
Companies like
Abbott Laboratories (US)
Thermo Fisher Scientific (US)
Siemens Healthineers AG (Germany)
Nova Biomedical (US)
Quidel Corporation (US)
F. Hoffman-La Roche Ltd. (Switzerland)
Danaher Corporation (US)
Becton, Dickinson and Company (US)
Chembio Diagnostics (US)
EKF Diagnostics (UK)
Trinity Biotech plc (Ireland)
Instrumentation Laboratory (a Werfen Company) (US)
PTS Diagnostics (US)
Sekisui Diagnostics (US)
bioMérieux S.A. (France)
Abbott Laboratories is the leading market player in point-of-care diagnostics owing to continuous investments in R&D, a strong focus on strengthening its brand presence, broad customer base, and strong geographical foothold. Abbott is also engaged in the development of novel products and improving its existing product line and processes. Furthermore, the POC diagnostics business is witnessing expansion in domestic and emerging markets through acquisitions and collaborations with other players.
Notable happenings in the Global Point of Care (POC) Diagnostics/Testing Market in the recent past:
Product Launch - In January 2022, Roche announced the launch of its Cobas Pulse System in countries accepting the CE Mark. Cobas Pulse System is a connected point-of-care solution for professional blood glucose management.
Investment - In April 2021, FIND, the global alliance for diagnostics, invested USD 21 million in Biomeme, Bioneer, Qlife, and SD Biosensor, to promote the development, manufacturing, and launch of affordable point-of-care molecular diagnostic platforms to detect multiple pathogens that cause diseases including COVID-19.
Acquisition - In June 2021, bioMérieux signed a co-exclusive distribution agreement with Specific Diagnostics for the SPECIFIC REVEAL Rapid AST system in Europe.
Product Approval - In October 2021, Thermo Fisher Scientific was granted Emergency Use Authorization (EUA) by the FDA to conduct COVID-19 tests using the new saliva sample collection method with the SpectrumDNA SDNA-1000 collection device.
Investment- In November 2021, the US Department of Health and Human Services invested USD 650 million from the American Rescue Plan to increase rapid molecular point-of-care diagnostic tests for SARS-CoV-2
Collaboration - In January 2020, Roche Diagnostics updated its collaboration with Inotrem S.A. for the development of a rapid blood test for septic shock. The collaboration is targeted toward developing a companion diagnostic test to measure sTREM-1 levels in the bloodstream.
Product Launch - In March 2020, Nova Biomedical announced the launch of the Stat EMS Basic blood testing system to be used in emergency and ambulance care in CE-regulated countries.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
